Evidence map›Paper›PMID 40114866›Full record

ArticleIndian journal of surgical oncology2025

Triumph Over Butchery: Guest Editorial for Indian Journal of Surgical Oncology.

Aradhya Nigam, Ashok R Shaha

Abstract readEditorial
In one paragraph

Article in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aradhya NigamDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY USA.
Ashok R ShahaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While once considered "butchery," thyroid cancer surgery is now considered a safe surgery in the setting of the increasing incidence of thyroid nodules. Several changes in the approach to patients and advancements in technology have paved the way for the technical feasibility of thyroid surgery. International guidelines have enabled a personalized, and less invasive approach to patients and thus reducing the morbidity attributed tumors from potential injury to the recurrent laryngeal nerve or long-term thyroid hormone replacement- particularly for papillary microcarcinomas. Morbidity from hypocalcemia and nerve injury have further been improved by advancements including parathyroid localizing technology, nerve monitoring, molecular testing, and improved diagnostic imaging. As we continue to improve our understanding of the thyroid, so will the outcomes of patients who undergo thyroid cancer surgery. Advancements in the safety and feasibility of thyroid surgery remind us of the statement made by William Halsted: "thyroid surgery is a supreme triumph of the surgeon's heart."

Indexed as

Advancements in thyroid surgeryPTCThyroid carcinoma

Identifiers

PMID40114866
PMCPMC11920522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.